UPDATE : Monday, September 7, 2020
상단여백
Menarini Korea deletes controversial YouTube ad
Menarini Korea’s online advertisement of an athlete’s foot treatment depict...
by Kim Chan-hyuk  |  2020-07-16 14:16
라인
US-based Psomagen stocks shot up on 1st day of Kosdaq listing
The shares prices of Psomagen, a U.S.-based company specializing in genome ...
by Kim Chan-hyuk  |  2020-07-13 14:56
라인
Biotech firms offer bonus shares to increase liquidity
Four listed biotech companies have announced a bonus issue in the past week...
by Kim Chan-hyuk  |  2020-07-09 14:10
라인
Drugmakers appeal limited insurance benefit for dementia drug choline alfoscerate
Sixty-six manufacturers of choline alfoscerate, a dementia drug, filed an a...
by Kim Chan-hyuk  |  2020-07-09 12:52
라인
[News Focus] Who will win BTX strain dispute – Daewoong or Medytox?
The U.S. International Trade Commission (ITC) is to give a preliminary ruli...
by Kim Chan-hyuk  |  2020-07-06 11:50
라인
‘Transabdominal cerclage raises neonatal survival’
Transabdominal cerclage in women with cervical incompetence could improve t...
by Kim Chan-hyuk  |  2020-07-03 15:52
라인
Minimally invasive TAVI procedure allows fast discharge for heart patients
Seoul St. Mary’s Hospital’s Cardio-cerebrovascular Center said Tuesday it h...
by Kim Chan-hyuk  |  2020-07-03 13:37
라인
KPBMA to expand local drugmakers’ exchanges with Europe
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) s...
by Kim Chan hyuk  |  2020-06-30 14:09
라인
Bukwang to change clinical design for Covid-19 drug candidate
Bukwang Pharm said it would modify the clinical trial design on Levovir (cl...
by Kim Chan-hyuk  |  2020-06-30 13:18
라인
Samsung Bioepis’ drug to join bevacizumab biosimilar competition in Europe
Samsung Bioepis’ Aybintio is expected to heat up biosimilars competition re...
by Kim Chan hyuk  |  2020-06-29 16:08
여백
여백
여백
Back to Top